- Lee H Schwamm, MD
- Anand Viswanathan, MD, PhD
This program focuses on administering urgent treatment with intravenous tissue-type plasminogen activator (IV tPA), which has been shown to improve outcomes in patients with ischemic stroke if administered within three hours from the onset of symptoms.
Despite its efficacy, 69% of hospitals in the United States do not use thrombolytic therapy and only about one percent of stroke patients receive it, mostly at hospitals with a high volume of stroke patients. Concerns by clinicians regarding the risk of intracerebral hemorrhage and liability exposure are among the contributing factors to the under use of tPA, underscoring the need for continuing education to assist clinicians in developing sound stroke-related diagnostic skills.
At the end of this educational activity, participants should be able to:
- Recognize the clinical signs and symptoms of hemorrhagic versus ischemic CNS stroke and the conditions that mimic them.
- Express the basic competencies of stroke evaluation by using the NIH Stroke Scale and appropriately initiating intravenous tissue plasminogen activator (IV tPA).
Vice Chairman, Department of Neurology
Director, TeleStroke & Acute Stroke Services
MD, PhD, Emory University Residency, Brigham and Women's Hospital Fellowship, Hopital Lariboisiere Fellowship, Massachusetts General Hospital
Release Date: June 1, 2010
Expiration Date: June 1, 2013
To receive credit for this activity, listen to the presentations and complete the post-test and activity evaluations.
This enduring material has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.
McLean Hospital designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.
The following planners of this activity have indicated that neither they nor their spouse/partner have a relevant financial relationship to disclose:
John A. Fromson, MD; Reviewer
Tristan Gorrindo, MD
Robert J. Birnbaum, Md, PhD
Anan Nathif, EdM
Speaker DisclosuresThe following speakers of this activity have indicated that neither they nor their spouse/partner have a relevant financial relationship to disclose:
We are committed to giving learners the most comprehensive view of disclosure information. For this reason, in addition to listing the disclosures specific to this activity, we also maintain a database of global disclosures for all faculty who plan or speak at our activities. Biographical information for each facutly is also included. To view a specific speaker or planner’s global disclosure, please click on the appropriate link below.
Lee H Schwamm, MD
Anand Viswanathan, MD, PhD
Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
This program has received support in the form of educational grants from the following companies: